NEW YORK (Reuters Health) – Among patients with myeloma treated with thalidomide, antithrombotic prophylactic therapies with aspirin, warfarin or enoxaparin reduce thromboembolic events to a similar degree, according…
NEW YORK (Reuters Health) – Insulin degludec, an ultra-long-acting basal insulin, provides glycemic control in type 1 diabetes similar to that of insulin glargine but with lower occurrence…
NEW YORK (Reuters Health) – A new study questions the “universal definition” of percutaneous coronary intervention (PCI)-related myocardial infarction (MI type 4a) — an increase of the biomarkers…
NEW YORK (Reuters Health) – The combination of fibrate and statin therapy is a safe and efficacious treatment option for women with multiple lipid abnormalities, a multicenter team…
NEW YORK (Reuters Health) – Atrial flutter seen in patients in the emergency department (ED) resolves more often with electrical cardioversion than with antiarrhythmic drug treatment, and long-term…
NEW YORK (Reuters Health) – Cardiac resynchronization therapy added to optimal medical therapy or in addition to an implantable cardioverter defibrillator (ICD) reduces mortality significantly in mild to…
NEW YORK (Reuters Health) – The selective sinoatrial I-f current inhibitor ivabradine lowers heart rate in patients with stable coronary artery disease and impaired left ventricular systolic function…
NEW YORK (Reuters Health) – Adding ketamine to propofol may improve the quality of sedation for painful procedures in the emergency department but it doesn’t reduce the frequency…
NEW YORK (Reuters Health) – For treatment of uncomplicated skin abscesses, the efficacy of ultrasound-guided needle aspiration is not on par with incision and drainage – it doesn’t…